Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125876572 | 12587657 | 2 | F | 201406 | 20160922 | 20160725 | 20160930 | PER | US-009507513-1607USA003825 | MERCK | 72.00 | YR | F | Y | 0.00000 | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125876572 | 12587657 | 1 | PS | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 50 MG, ONCE A DAY | 20386 | 50 | MG | TABLET | QD | ||||||
| 125876572 | 12587657 | 2 | C | ASPIRIN. | ASPIRIN | 1 | 160 MG ONCE A DAY IN THE MORNING | U | 0 | 160 | MG | TABLET | QD | ||||||
| 125876572 | 12587657 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 160 MG ONCE A DAY IN THE MORNING | U | 0 | 160 | MG | TABLET | QD | ||||||
| 125876572 | 12587657 | 4 | C | PREDNISONE. | PREDNISONE | 1 | 2.5 MG, QD | U | 0 | 2.5 | MG | TABLET | QD | ||||||
| 125876572 | 12587657 | 5 | C | PREDNISONE. | PREDNISONE | 1 | 2.5 MG, QD | U | 0 | 2.5 | MG | TABLET | QD | ||||||
| 125876572 | 12587657 | 6 | C | SALSALATE. | SALSALATE | 1 | 1500 MG, TWO TIMES A DAY | U | 0 | BID | |||||||||
| 125876572 | 12587657 | 7 | C | SALSALATE. | SALSALATE | 1 | 1500 MG, TWO TIMES A DAY | U | 0 | BID | |||||||||
| 125876572 | 12587657 | 8 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 50 MG, UNK | U | 0 | 50 | MG | ||||||||
| 125876572 | 12587657 | 9 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 100 MG, UNK | U | 0 | 100 | MG | ||||||||
| 125876572 | 12587657 | 10 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 100 MG, UNK | U | 0 | 100 | MG | ||||||||
| 125876572 | 12587657 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK, ON MONDAYS AND WEDNESDAYS | 0 | |||||||||||
| 125876572 | 12587657 | 12 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 2000 MG, UNK | 0 | |||||||||||
| 125876572 | 12587657 | 13 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 400 MG, TWO TIMES A DAY | 0 | 400 | MG | BID | ||||||||
| 125876572 | 12587657 | 14 | C | CALCIUM (UNSPECIFIED) | CALCIUM | 1 | UNK, ONCE A DAY | 0 | QD | ||||||||||
| 125876572 | 12587657 | 15 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 20 MG, EVERY OTHER DAY | 0 | 20 | MG | QOD | ||||||||
| 125876572 | 12587657 | 16 | C | BUSPIRONE HYDROCHLORIDE. | BUSPIRONE HYDROCHLORIDE | 1 | ONE AND A HALF IN THE MORNING AND ONE IN THE EVENING | 0 | BID | ||||||||||
| 125876572 | 12587657 | 17 | C | NUVIGIL | ARMODAFINIL | 1 | 250 MG, UNK | 0 | 250 | MG | |||||||||
| 125876572 | 12587657 | 18 | C | MYRBETRIQ | MIRABEGRON | 1 | 200 (UNITS NOT PROVIDED), UNK | 0 | 200 | DF | |||||||||
| 125876572 | 12587657 | 19 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | 0.5 (UNITS NOT PROVIDED), AT BED TIME | 0 | .5 | DF | QD | ||||||||
| 125876572 | 12587657 | 20 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 125876572 | 12587657 | 21 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | UNK | 0 | |||||||||||
| 125876572 | 12587657 | 22 | C | VICTOZA | LIRAGLUTIDE | 1 | 1.8 (UNITS NOT PROVIDED), EVERY DAY | 0 | 1.8 | DF | QD | ||||||||
| 125876572 | 12587657 | 23 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125876572 | 12587657 | 24 | C | FLECAINIDE | FLECAINIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125876572 | 12587657 | 1 | Hypertension |
| 125876572 | 12587657 | 2 | Cardiac disorder |
| 125876572 | 12587657 | 8 | Bipolar disorder |
| 125876572 | 12587657 | 15 | Cardiac disorder |
| 125876572 | 12587657 | 17 | Narcolepsy |
| 125876572 | 12587657 | 18 | Bladder disorder |
| 125876572 | 12587657 | 19 | Restless legs syndrome |
| 125876572 | 12587657 | 22 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125876572 | 12587657 | Cardiac disorder | |
| 125876572 | 12587657 | Dizziness | |
| 125876572 | 12587657 | Drug interaction | |
| 125876572 | 12587657 | Heart rate decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125876572 | 12587657 | 2 | 201406 | 0 | ||
| 125876572 | 12587657 | 4 | 201406 | 0 | ||
| 125876572 | 12587657 | 6 | 201406 | 0 | ||
| 125876572 | 12587657 | 9 | 201406 | 0 |